Xtrackers MSCI World Ex Usa UCITS ETF (LON:EXUS)
London
· Delayed Price · Currency is GBP · Price in USD 36.80
-0.10 (-0.26%)
Jun 13, 2025, 4:35 PM BST
14.71% (1Y)
| Assets | 2.98B |
| Expense Ratio | 0.15% |
| PE Ratio | 17.24 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +14.71% |
| Volume | 217,410 |
| Open | 36.90 |
| Previous Close | 36.90 |
| Day's Range | 36.41 - 36.90 |
| 52-Week Low | 29.12 |
| 52-Week High | 37.22 |
| Beta | 0.79 |
| Holdings | 783 |
| Inception Date | Mar 6, 2024 |
About EXUS
The fund is passively managed. DESCRIPTION OF INDEX: The aim is for your investment to track the performance, before fees and expenses, of the MSCI World ex USA Index (index) which is designed to reflect the performance of companies from global developed markets, excluding the United States of America.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol EXUS
Provider Xtrackers
Index Tracked MSCI World ex USA
Performance
EXUS had a total return of 14.71% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.98%.
Top 10 Holdings
13.31% of assets| Name | Symbol | Weight |
|---|---|---|
| Bought Usd/Sold Eur | n/a | 2.10% |
| Bought Usd/Sold Jpy | n/a | 1.62% |
| SAP SE | SAP | 1.51% |
| ASML Holding N.V. | ASML | 1.40% |
| Nestlé S.A. | NESN | 1.34% |
| Roche Holding AG | ROG | 1.09% |
| Novartis AG | NOVN | 1.08% |
| AstraZeneca PLC | AZN | 1.08% |
| Novo Nordisk A/S | NOVO.B | 1.07% |
| HSBC Holdings plc | HSBA | 1.01% |